Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of GTC BIOTHERAPEUTICS, INC. patents

List of GTC BIOTHERAPEUTICS, INC. patents

List of SatCon Technology Corporation patents

List of Sure Universal patents

List of JAVAD GNSS patents

List of firearms patents

List of companies in GrowthWorks Atlantic Venture Fund's investment portfolio

Patents where

Current Assignee

Name

is

‌

GTC BIOTHERAPEUTICS, INC.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7550263 Method for the production of fusion proteins in transgenic mammal milk	Patent 7550263 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on June, 2009 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7550263	June 23, 2009
	‌ US Patent 7271312 Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems	Patent 7271312 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on September, 2007 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7271312	September 18, 2007
	‌ US Patent 7501553 Non-human transgenic mammal comprising a modified MSP-1 nucleic acid	Patent 7501553 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on March, 2009 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7501553	March 10, 2009
	‌ US Patent 7354594 Merozoite surface protein 1 lacking glycosylation sites	Patent 7354594 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on April, 2008 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7354594	April 8, 2008
	‌ US Patent 7531632 Clarification of transgenic milk using depth filtration	Patent 7531632 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on May, 2009 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7531632	May 12, 2009
	‌ US Patent 7087719 Method for the crystallization of human serum albumin	Patent 7087719 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on August, 2006 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7087719	August 8, 2006
	‌ US Patent 7101971 Erythropoietin analog-human serum albumin fusion	Patent 7101971 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on September, 2006 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7101971	September 5, 2006
	‌ US Patent 7928064 Transgenically produced antithrombin III	Patent 7928064 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on April, 2011 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7928064	April 19, 2011
	‌ US Patent 8173860 Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion	Patent 8173860 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on May, 2012 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	8173860	May 8, 2012
	‌ US Patent 7632980 Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems	Patent 7632980 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on December, 2009 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7632980	December 15, 2009
	‌ US Patent 7045676 Transgenic animals secreting proteins into milk	Patent 7045676 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on May, 2006 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7045676	May 16, 2006
	‌ US Patent 7019193 Treatments using transgenic goat produced antithrombin III	Patent 7019193 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on March, 2006 by the United States Patent and Trademark Office.		‌ GTC BIOTHERAPEUTICS, INC.		United States Patent and Trademark Office	7019193	March 28, 2006

12 results

0 selected

12 results

0 selected